384 related articles for article (PubMed ID: 34204372)
41. Differential expression of tissue inhibitor of metalloproteinases-2 by cutaneous squamous and basal cell carcinomas.
Wagner SN; Ockenfels HM; Wagner C; Soyer HP; Goos M
J Invest Dermatol; 1996 Feb; 106(2):321-6. PubMed ID: 8601735
[TBL] [Abstract][Full Text] [Related]
42. The immunoexpression of MMP-1 and MMP-13 in eyelid basal cell carcinoma.
Mercuţ IM; Simionescu CE; Stepan AE; Andreiana BC; Ciurea AM; Mercuţ R; Ciurea ME
Rom J Morphol Embryol; 2020; 61(4):1221-1226. PubMed ID: 34171070
[TBL] [Abstract][Full Text] [Related]
43. Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion.
Vosseler S; Lederle W; Airola K; Obermueller E; Fusenig NE; Mueller MM
Int J Cancer; 2009 Nov; 125(10):2296-306. PubMed ID: 19610062
[TBL] [Abstract][Full Text] [Related]
44. Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES.
Aoki M; Pawankar R; Niimi Y; Kawana S
Int Arch Allergy Immunol; 2003 Mar; 130(3):216-23. PubMed ID: 12660426
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency.
Jee SH; Shen SC; Chiu HC; Tsai WL; Kuo ML
Oncogene; 2001 Jan; 20(2):198-208. PubMed ID: 11313947
[TBL] [Abstract][Full Text] [Related]
46. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
47. Basal cell carcinoma arising in outdoor workers versus indoor workers: a retrospective study.
Husein-Elahmed H; Gutierrez-Salmeron MT; Aneiros-Cachaza J; Naranjo-Sintes R
Cutis; 2017 Jan; 99(1):55-60. PubMed ID: 28207005
[TBL] [Abstract][Full Text] [Related]
48. Differential expression patterns of MMPs and their role in the invasion of epithelial premalignant tumors and invasive cutaneous squamous cell carcinoma.
Roh MR; Zheng Z; Kim HS; Kwon JE; Jeung HC; Rha SY; Chung KY
Exp Mol Pathol; 2012 Apr; 92(2):236-42. PubMed ID: 22305927
[TBL] [Abstract][Full Text] [Related]
49. Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19-deficient mice.
Jost M; Folgueras AR; Frérart F; Pendas AM; Blacher S; Houard X; Berndt S; Munaut C; Cataldo D; Alvarez J; Melen-Lamalle L; Foidart JM; López-Otín C; Noël A
Cancer Res; 2006 May; 66(10):5234-41. PubMed ID: 16707448
[TBL] [Abstract][Full Text] [Related]
50. Regulation of MMPs during melanoma progression: from genetic to epigenetic.
Frank A; David V; Aurelie TR; Florent G; William H; Philippe B
Anticancer Agents Med Chem; 2012 Sep; 12(7):773-82. PubMed ID: 22292748
[TBL] [Abstract][Full Text] [Related]
51. MMP-TIMP interactions in cancer invasion: An evolutionary game-theoretical framework.
Salimi Sartakhti J; Manshaei MH; Sadeghi M
J Theor Biol; 2017 Jan; 412():17-26. PubMed ID: 27670802
[TBL] [Abstract][Full Text] [Related]
52. [Immunohistochemical study of the specific features of expression of matrix metalloproteinases 1, 9 in the photoaged skin, the foci of actinic keratosis and basal cell carcinoma].
Kuznetsova EV; Snarskaya ES; Zavalishina LE; Tkachenko SB
Arkh Patol; 2016; 78(6):17-22. PubMed ID: 28139598
[TBL] [Abstract][Full Text] [Related]
53. [Role of tumor microenvironment in the formation and progression of skin melanoma].
Olbryt M
Postepy Hig Med Dosw (Online); 2013 May; 67():413-32. PubMed ID: 23756376
[TBL] [Abstract][Full Text] [Related]
54. Can smoking and/or occupational UV exposure have any role in the development of the morpheaform basal cell carcinoma? A critical role for peritumoral mast cells.
Erbagci Z; Erkiliç S
Int J Dermatol; 2002 May; 41(5):275-8. PubMed ID: 12100702
[TBL] [Abstract][Full Text] [Related]
55. Cathepsin K expression in basal cell carcinoma.
Ishida M; Kojima F; Okabe H
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e128-30. PubMed ID: 22220587
[TBL] [Abstract][Full Text] [Related]
56. A study on angiogenesis-related matrix metalloproteinase networks in primary hepatocellular carcinoma.
Ishii Y; Nakasato Y; Kobayashi S; Yamazaki Y; Aoki T
J Exp Clin Cancer Res; 2003 Sep; 22(3):461-70. PubMed ID: 14582707
[TBL] [Abstract][Full Text] [Related]
57. Matrix metalloproteinases: multifunctional contributors to tumor progression.
McCawley LJ; Matrisian LM
Mol Med Today; 2000 Apr; 6(4):149-56. PubMed ID: 10740253
[TBL] [Abstract][Full Text] [Related]
58. Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma.
Kurizaki T; Toi M; Tominaga T
Oncol Rep; 1998; 5(3):673-7. PubMed ID: 9538174
[TBL] [Abstract][Full Text] [Related]
59. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
60. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness.
Culhaci N; Metin K; Copcu E; Dikicioglu E
BMC Cancer; 2004 Aug; 4():42. PubMed ID: 15291964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
